{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:24Z","timestamp":1791389544446,"version":"4.3.3"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jgar.2019.01.032","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T19:56:23Z","timestamp":1549828583000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Pooled prevalence and trends of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates over the past 10 years in Turkey: A meta-analysis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-5112","authenticated-orcid":false,"given":"Ali","family":"Acar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Karaahmeto\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halis","family":"Akal\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aybala F.","family":"Altay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jgar.2019.01.032_bib0005","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1164\/ajrccm.160.3.9901107","article-title":"Severe community-acquired pneumonia. Risk factors and follow-up epidemiology","volume":"160","author":"Ruiz","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jgar.2019.01.032_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0034-7094(13)70199-5","article-title":"Three-year evaluation of nosocomial infection rates of the ICU","volume":"63","author":"Dereli","year":"2013","journal-title":"Braz J Anesthesiol"},{"issue":"5","key":"10.1016\/j.jgar.2019.01.032_bib0015","doi-asserted-by":"crossref","first-page":"PH29","DOI":"10.12659\/MSM.881750","article-title":"Nosocomial infections and risk factors in the intensive care unit of a teaching and research hospital: a prospective cohort study","volume":"17","author":"Ak","year":"2011","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.jgar.2019.01.032_bib0020","first-page":"227","article-title":"Catheter-associated urinary tract infections in intensive care units at a university hospital in Turkey","volume":"14","author":"Keten","year":"2014","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.jgar.2019.01.032_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2047-2994-3-32","article-title":"Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis","volume":"3","author":"Nathwani","year":"2014","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10.1016\/j.jgar.2019.01.032_bib0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5578\/mb.9734","article-title":"Changes in antibiotic resistance of Pseudomonas aeruginosa isolates over the past 11 years in Turkey: a meta-analysis","volume":"49","author":"Aykan","year":"2015","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jgar.2019.01.032_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systemic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2019.01.032_bib0040","series-title":"Cochrane handbook for systematic reviews of Interventions","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jgar.2019.01.032_bib0045","series-title":"Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline","author":"National Committee for Clinical Laboratory Standards","year":"2002"},{"key":"10.1016\/j.jgar.2019.01.032_bib0050","unstructured":"http:\/\/www.eucast.org. [Accessed 23 February 2018]."},{"issue":"4","key":"10.1016\/j.jgar.2019.01.032_bib0055","first-page":"537","article-title":"Resistance to newer beta-lactams and related ESBL types in Gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study","volume":"42","author":"G\u00fcr","year":"2008","journal-title":"Mikrobiyol Bul"},{"issue":"4","key":"10.1016\/j.jgar.2019.01.032_bib0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1179\/joc.2009.21.4.383","article-title":"Antimicrobial resistance in Gram-negative hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007","volume":"21","author":"Gur","year":"2009","journal-title":"J Chemother"},{"issue":"9","key":"10.1016\/j.jgar.2019.01.032_bib0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ajic.2014.05.029","article-title":"International nosocomial infection control consortium (INICC) report, data summary of 43 countries for 2007-2012. Device associated module","volume":"42","author":"Rosenthal","year":"2014","journal-title":"Am J Infect Control"},{"issue":"6","key":"10.1016\/j.jgar.2019.01.032_bib0070","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","article-title":"Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risk associated with different antipseudomonal agents","volume":"43","author":"Carmeli","year":"1999","journal-title":"Antimicrob Agents Chemoter"},{"issue":"4","key":"10.1016\/j.jgar.2019.01.032_bib0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bjid.2012.06.009","article-title":"Risk factor for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy","volume":"16","author":"Tuon","year":"2012","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2019.01.032_bib0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1120009X.2016.1156893","article-title":"Antibiotic consumption in Turkish hospitals; a multi-centre point prevalence study","volume":"29","author":"Guclu","year":"2017","journal-title":"J Chemother"},{"issue":"4","key":"10.1016\/j.jgar.2019.01.032_bib0085","first-page":"701","article-title":"Surveillance of antimicrobial use in a Turkish university hospital","volume":"41","author":"Saba","year":"2011","journal-title":"T\u00fcrk J Med Sci"},{"issue":"2","key":"10.1016\/j.jgar.2019.01.032_bib0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0255-0857.81788","article-title":"Evaluation of the therapeutic use of antibiotics in Aegean region hospitals of Turkey: a multicentric study","volume":"29","author":"Ozgen\u00e7","year":"2011","journal-title":"Indian J Med Microbiol"},{"issue":"2","key":"10.1016\/j.jgar.2019.01.032_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jiph.2013.09.007","article-title":"Analysis of antimicrobial consumption and cost in a teaching hospital","volume":"7","author":"Bozkurt","year":"2014","journal-title":"J Infect Public Health"},{"issue":"4","key":"10.1016\/j.jgar.2019.01.032_bib0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jhin.2016.08.012","article-title":"Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality","volume":"94","author":"Erg\u00f6n\u00fcl","year":"2016","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.jgar.2019.01.032_bib0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:56:07Z","timestamp":1761990967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519300396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"alternative-id":["S2213716519300396"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.032","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pooled prevalence and trends of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates over the past 10 years in Turkey: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}